Skip to main content
. 2010 Jul 23;5(7):e11765. doi: 10.1371/journal.pone.0011765

Figure 6. Silencing of NLRP3 attenuates cholesterol crystal (CHC)-induced IL-1β secretion.

Figure 6

(A) NLRP3 mRNA levels were reduced by 72% after treatment of THP-1 macrophages with NLRP3-targeted small interfering RNA (siRNA). (B) CHC-induced IL-1β secretion was abolished after treatment of cells with NLRP3 siRNA, whereas treatment of cells with negative control siRNA had no effect. The data are means ± s.e.m. from 5 (A) and 3 (B) experiments. ** = p<0.01.